Debora Collotta, and Massimo Collino. “NLRP3 Inflammasome Signaling Platform As New Pharmacological Target for Metaflammation”. Diabetes Research, vol. 3, no. 1, Dec. 2016, pp. e1-e3, doi:10.17140/DROJ-3-e008.